Getting to know our products 2021_Company News_Senova Technology Co., Ltd.

+86-0755-3337-2138/2139

info@senovatech.com

Home

About

Product

Service

News

Join

Contact

Home

About

Product

APIs

Anti-Viral

Anti-Infection

Anti-Bacteria

Anti-Coagulants

Anti-Cancer

Advance Intermediates

Advance Intermediates

Peptides

Peptides

Fine Chemicals

Fine Chemicals

Others

Others

Service

News

Company news

Industry news

Company statement

Join

Contact

LNK

TOP

WE USE COOKIES ON OUR WEBSITE

This website uses Cookies to help improve your user experience.

MAYBE LATER

look over

I AGREE

/ Home / News / Company News /

Getting to know our products 2021

Getting to know our products 2021

Release Time: 2021-06-29

News Source: SenovaTech

Author: Operation Dept.

Currently, Senova is focusing on anti-covid drugs materials such as Remdesivir / Favipiravir / Molnupiravir / Baricitinib and related intermediates, feel free to contact our email sales@senovatech.com for more details.

Thanks and wish all are fine despite of COVID-2019 epidemic!

2021 JUNE 29

Previous

Next

Company News

Relocation Notice

Participating in CPHI Worldwid

Senova to Attend CPHI Worldwid

SenovaTech Team Triumphs at CP

Senova Team to Participate in

Congratulations on the success

"Business Trip to Japan's Phar

Industry News

Biden Administration Proposes

Novo's semaglutide reduced ris

Lilly to invest US$ 4.5 bn in

Recent news about Eli Lilly an

US Biosecure Act to restrict b

Novo's weight-loss drug Saxend

How to choose between semaglut

Learn more about Tirzepatide

GLP-1 drug shortages create US

Lilly to sell Zepbound vials d

Semaglutide Usage and Storage

Semaglutide is a revolutionary

US court rules for AstraZeneca

Zealand Pharma seeks big pharm

Lilly, Novo Nordisk battle for

Weight loss drug's trial resul

PHARMA Novo Nordisk posts 'bes

In warning letters, FDA tells

Company Statement

SENOVA email(Anne@senovatech.c

In warning letters, FDA tells